<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>16</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2015</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Expression of Cox-2 and Bcl-2 in Paget’s Disease of the Breast</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>1041</FirstPage>
			<LastPage>1045</LastPage>
			<ELocationID EIdType="pii">30546</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>&lt;b&gt;Background:&lt;/b&gt; Paget’s disease (PD) is a rare form of intraepithelial adenocarcinoma that involves breast andextramammarian tissues. It is often associated with ductal carcinoma in situ and/or invasive ductal cancer.Molecular pathways that play a role in development of Paget’s disease are stil unclear. Expression patterns ofCox-2 and bcl-2 were therefore assessed. Materials and &lt;br/&gt;&lt;b&gt;Methods&lt;/b&gt;: Patients with a histopathological diagnosis ofPaget’s disease were included in this study. Patient files were analysed retrospectively. &lt;br/&gt;&lt;b&gt;Results&lt;/b&gt;: Invasive cancerwas diagnosed in 35 (76.1%) of the patients, 7 (15.2%) had ductal carcinoma in situ and 4 (8.7%) patients had noassociated neoplasm. Twenty four (52.2%) patients showed COX-2 expression in Paget cells whereas no expressionwas seen in 22 (47.8%) patients. No relation was found between COX-2 expression and the lesion underlyingPaget’s disease (p=0.518). Bcl-2 expression in Paget cells was found positive in 12 (26.1%) and negative in 27(58,7%) cases. There was no relation between Bcl-2 expression and the lesion accompanying Paget’s disease(p=0.412). No relation was observed between COX-2 expression and Bcl-2 expression (p=0.389). &lt;br/&gt;&lt;b&gt;Conclusions&lt;/b&gt;:In breast cancer, COX-2 expression is associated with poor prognostic factors. As COX-2 expression increasesthe tendency to metastasize also increases. In our study we found a significantly high COX-2 expression inPaget’s disease of the breast. We suggest that COX-2 expression and inflammatory processes may play a rolein pathogenesis of the Paget’s disease of the breast.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Paget’s disease</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">breast cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">COX-2</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Bcl-2</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Inflammation</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_30546_d3e0448a7d2bab089e505cae89837e2a.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
